Financial Regulatory Administration mandates insurers to assess product compliance and suitability, and promptly adjust or cease selling unsuitable products

Deep News
3小时前

On October 9, a financial news flash reported that the Financial Regulatory Administration recently issued the "Regulations on the Development and Management of Insurance Products for Property Insurance Companies" (hereinafter referred to as the "Regulations"). An official from the relevant department of the Financial Regulatory Administration stated that the "Regulations" consistently integrate strengthening product supervision, standardizing development management, and protecting consumer rights throughout.

The first is to adhere to the essence of insurance. It clearly stipulates that the development of insurance products must follow principles such as insurable interest, loss compensation, good faith, aleatory contract, and risk pricing. It prohibits the development of insurance products that lack contingency, underwrite speculative risks, have no actual protection content, or are purely for malicious speculation, or violate public order and good morals.

The second is to strengthen standards and norms. It requires that the wording of clauses adhere to standardization and normalization, proposing that individual clauses should be easy to understand and clear. For content that exempts or reduces the insurer's liability, it should be presented in a manner sufficient to draw the policyholder's attention, thereby effectively safeguarding consumers' right to know.

The third is to strictly manage responsibilities. It refines and clarifies the product development management responsibilities that should be borne at all levels of the company, and requires property insurance companies to establish internal accountability mechanisms to urge companies to develop products prudently.

The fourth is to strengthen continuous supervision. It requires insurance companies to assess product compliance and suitability, promptly adjust or cease selling products that are not suitable for continued sale, and strengthen full-process management of products.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10